LYRA Competitors & Alternatives

Compare Lyra Therapeutics Inc with similar stocks in the same industry

Biotechnology

LYRA

Main Stock
$0.50
-62.50%
Tradestie Score
44
Market Cap
$10.80M
Revenue Growth
-87.2%
Analyst Upside
+3132.3%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Delivery
Competitive Moat: None
Core Technology Stack: XTreo platform, drug-eluting implants
Major Customers 3
ENT clinics hospitals clinical trial sites
Critical Suppliers 2
contract manufacturers API suppliers
Direct Ecosystem Rivals 2

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
NVCT Nuvectis Pharma, Inc. Common Stock
$19.18
+0.37%
$154.27M - 54 Compare
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$7.07
-0.70%
$137.59M - 37 Compare
CLYM Climb Bio, Inc. Common Stock
$9.63
-3.12%
$133.50M - 45 Compare
SRZN Surrozen, Inc. Common
$30.16
-6.68%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$25.11
-7.41%
$110.20M - 34 Compare
PLRX Pliant Therapeutics, Inc. Common Stock
$0.67
-3.53%
$89.01M - 39 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.03
+0.17%
$84.52M - 53 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.20
-3.74%
$67.94M - 52 Compare
PASG Passage Bio, Inc. Common Stock
$4.20
+1.57%
$25.84M - 20 Compare
OPNT OPNT
- - - - Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 3841)

219 stocks in this industry